FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)

View source ↗

Summary

FDA approved a supplemental application for epinephrine from BPI Labs, LLC, confirming regulatory action on the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Reaction
• Anaphylaxis
• Asthma
• Cardiac Arrest

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)

Snippet

SUPPL AP for EPINEPHRINE (EPINEPHRINE)